(Q38332853)

2 September 2017

miR-21 modulates cell apoptosis by targeting multiple genes in renal cell carcinoma (English)

1 reference

2 September 2017

0 references

Aimin Zhang

1

1 reference

2 September 2017

Yi Liu

2

1 reference

2 September 2017

Yizhen Shen

3

1 reference

2 September 2017

Youhe Xu

4

1 reference

2 September 2017

Xiangtie Li

5

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 August 2011

1 reference

2 September 2017

1 reference

2 September 2017

78

1 reference

2 September 2017

2

1 reference

2 September 2017

474.e13-9

1 reference

Chemotherapeutic drugs sensitize human renal cell carcinoma cells to ABT-737 by a mechanism involving the Noxa-dependent inactivation of Mcl-1 or A1.

2 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.03.030

Unique microRNA molecular profiles in lung cancer diagnosis and prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.03.030

hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.03.030

Identification of a microRNA panel for clear-cell kidney cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.03.030

Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell Renal Cell Carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.03.030

MicroRNA-21 down-regulates the expression of tumor suppressor PDCD4 in human glioblastoma cell T98G.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.03.030

MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.03.030

Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.03.030

FLIP and the death effector domain family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.03.030

Tissue inhibitor of metalloproteinase-3 induces apoptosis in prostate cancer cells and confers increased sensitivity to paclitaxel.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.03.030

TGFBI expression is associated with a better response to chemotherapy in NSCLC.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.03.030

YAP1 meets tumor suppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.03.030

Silencing of SPRY1 triggers complete regression of rhabdomyosarcoma tumors carrying a mutated RAS gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.03.030

Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.03.030

MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.03.030

MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.03.030

microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.03.030

miR-21: an androgen receptor-regulated microRNA that promotes hormone-dependent and hormone-independent prostate cancer growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.03.030

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.03.030

TRAIL receptor-2 signals apoptosis through FADD and caspase-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.03.030

Recent advances in understanding the cell death pathways activated by anticancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.03.030

Targeting apoptosis pathways in cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.03.030

Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.03.030

Functional dissection of the granzyme family: cell death and inflammation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.03.030

Apoptosis and cancer: mutations within caspase genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.03.030

Caspases: intracellular signaling by proteolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.03.030

MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.03.030

Foxo3a regulates apoptosis by negatively targeting miR-21

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.03.030

MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.03.030

Loss of expression of TIMP3 in clear cell renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2011.03.030

10.1016/J.UROLOGY.2011.03.030

7 January 2021

Identifiers

DOI

1 reference

2 September 2017

1 reference